References
- Aggarwal, P., et al., 2009. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Advanced drug delivery reviews, 61 (6), 428–437.
- Arnida, et al., 2011. Geometry and surface characteristics of gold nanoparticles influence their distribution and uptake by macrophages. European journal of pharmaceutics and biopharmaceutics, 77, 417–423.
- Barenholz, Y., 2007. In: Gregoriadis G, editor. Liposome technology. Vol. II. 3rd ed. New York: Informa, 1–25.
- Bonté, F. and Juliano, R.L., 1986. Interactions of liposomes with serum proteins. Chemistry and physics of lipids, 40 (2–4), 359–372.
- Briuglia, M.-L., et al., 2015. Influence of cholesterol on liposome stability and on in vitro drug release. Drug delivery and translational research, 5 (3), 231–242.
- Capriotti, A.L., et al., 2012. Do plasma proteins distinguish between liposomes of varying charge density? Journal of proteomics, 75 (6), 1924–1932.
- Caracciolo, G., 2015. Liposome-protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines. Nanomedicine, 11 (3), 543–557.
- de Meyer, F. and Smit, B., 2009. Effect of cholesterol on the structure of a phospholipid bilayer. Proceedings of the national academy of sciences of the United States of America, 106 (10), 3654–3658.
- Dimitrova, M.N., et al., 2000. Size dependence of protein-induced flocculation of phosphatidylcholine liposomes. Journal of colloid and interface science, 226 (1), 44–50.
- Frank, K.B. and Huang, L., 1995. Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery. Advanced drug delivery reviews, 16, 235–237.
- Gregoriadis, G., 1999. Long circulating liposomes: evolution of the concept. Targeting of drugs, 6, 1998.
- Hadjidemetriou, M., et al., 2015. In vivo biomolecule corona around blood-circulating, clinically used and antibody-targeted lipid bilayer nanoscale vesicles. ACS nano, 9 (8), 8142–8156.
- Hung, W., et al., 2007. The condensing effect of cholesterol in lipid bilayers. Biophysical journal, 92 (11), 3960–3967.
- Kirby, C., Clarke, J., and Gregoriadis, G., 1980. Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. The biochemical journal, 186 (2), 591–598.
- Law, S.L., et al., 1986. The adsorption of bovine serum albumin by liposomes. International journal of pharmaceutics, 32 (2–3), 237–241.
- Lee, Y.K., et al., 2015. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. International journal of nanomedicine, 10, 97–113.
- Lis, L.J., Kauffman, J.W., and Shriver, D.F., 1976. Raman spectroscopic detection and examination of the interaction of amino acids, polypeptides and proteins with the phosphatidylcholine lamellar structure. Biochimica et biophysica acta, 436 (3), 513–522.
- Mahmoud, M. and Ghannam, M., 2011. Stability of anionic liposomes in serum and plasma. African journal of pharmacy and pharmacology, 5 (16), 1898–1905.
- Marzban, E., et al., 2015. Optimizing the therapeutic efficacy of cisplatin PEGylated liposomes via incorporation of different DPPG ratios: in vitro and in vivo studies. Colloids and surfaces B: biointerfaces, 136, 885–891.
- McIntosh, T.J., 1978. The effect of cholesterol on the structure of phosphatidylcholine bilayers. Biochimica et biophysica acta, 513 (1), 43–58.
- Morrow, M.R., Whitehead, J.P., and Lu, D., 1992. Chain-length dependence of lipid bilayer properties near the liquid crystal to gel phase transition. Biophysical journal, 63 (1), 18–27.
- Okhil, K.N. and Awasthi, V., 2013. Surface engineering of liposomes for stealth behavior. Pharmaceutics, 5 (4), 542–569.
- Papahadjopoulos, D., et al., 1975. Effects of proteins on thermotropic phase transitions of phospholipid membranes. Biochimica et biophysica acta, 401 (3), 317.
- Papahadjopoulos, D., et al., 1991. Sterically stabilized liposomes: improvements in pharmacokinetics, tissue disposition and anti-tumour therapeutic efficacy. Proceedings of the national academy of sciences of the United States of America, 88 (24), 11460–11464.
- Patel, H.M., Tuzel, N.S., and Ryman, B.E., 1983. Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen. Biochimica et biophysica acta, 761 (2), 142–151.
- Pippa, N., Pispas, S., and Demetzos, C., 2012a. The fractal hologram and elucidation of the structure of liposomal carriers in aqueous and biological media. International journal of pharmaceutics, 430 (1–2), 65–73.
- Pippa, N., Pispas, S., and Demetzos, C., 2012b. The delineation of the morphology of charged liposomal vectors via a fractal analysis in aqueous and biological media: physicochemical and self-assembly studies. International journal of pharmaceutics, 437 (1–2), 26474.
- Rahman, M., et al., 2013. Protein–nanoparticle interactions. Berlin Heidelberg: Springer-Verlag; DOI: 10.1007/978-3-642-37555-2.
- Roerdink, F.H., et al., 1989. Effect of cholesterol on the uptake and intracellular degradation of liposomes by liver and spleen; a combined biochemical and gamma-ray perturbed angular correlation study. Biochimica et biophysica acta, 980 (2), 234–240.
- Róg, T., et al., 2009. Ordering effects of cholesterol and its analogues. Biochimica et biophysica acta, 1788 (1), 97–121.
- Sabín, J., et al., 2006. Size and stability of liposomes: a possible role of hydration and osmotic forces. The European physical journal E soft matter, 20 (4), 401–408.
- Sabín, J., et al., 2009. Interactions between DMPC liposomes and the serum blood proteins HSA and IgG. The journal of physical chemistry B, 113 (6), 1655–1661.
- Salmaso, S. and Caliceti, P., 2013. Stealth properties to improve therapeutic efficacy of drug nanocarriers. Journal of drug delivery.
- Santos, N.D., et al., 2007. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. Biochimica et biophysica acta (BBA) – biomembranes, 1768 (6), 1367–1377.
- Semple, S.C., Chonn, A., and Cullis, P.R., 1996. Influence of cholesterol on the association of plasma proteins with liposomes. Biochemistry, 35 (8), 2521–2525.
- Semple, S.C., Chonn, A., and Cullis, P.R., 1998. Interactions of liposomes and lipid-based carrier systems with blood proteins: relation to clearance behavior in vivo. Advanced drug delivery reviews, 32 (1–2), 3–17.
- Soema, P.C., et al., 2015. Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach. European journal of pharmaceutics and biopharmaceutics, 94, 427–435.
- Tierney, K.J., Block, D.E., and Longo, M.L., 2005. Elasticity and phase behavior of DPPC membrane modulated by cholesterol, ergosterol and ethanol. Biophysical journal, 89 (4), 2481–2493.
- Tsunoda, T., et al., 2001. Effects of lysozyme and bovine serum albumin on membrane characteristics of dipalmitoylphosphatidylglycerol liposomes. Colloids and surfaces B: biointerfaces, 20 (2), 155–163.
- Vroman, L., 1962. Effect of absorbed proteins on the wettability of hydrophilic and hydrophobic solids. Nature, 196, 476–477.
- Wolfram, J., et al., 2014. Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids and surfaces B: biointerfaces, 114, 294–300.
- Wolfram, J., et al., 2014. Thenano plasma interface: implications of the protein corona. Colloids and surfaces B: biointerfaces, 124, 17–24.
- Yeagle, P.L., 1985. Cholesterol and the cell membrane. Biochimica et biophysica acta, 822 (3–4), 267–287.
- Yokouchi, Y., et al., 2001. Effect of adsorption of bovine serum albumin on liposomal membrane characteristics. Colloids and surfaces B: biointerfaces, 20 (2), 95–103.
- Yukihiko, A., et al., 1995. Recognition of charged liposomes by rat peritoneal and splenic macrophages: effects of fibronectin on the uptake of charged liposomes. European journal of pharmaceutical sciences, 3 (2), 63–70.